Yu Cheng

5.2k total citations
88 papers, 4.1k citations indexed

About

Yu Cheng is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Yu Cheng has authored 88 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Biomedical Engineering, 33 papers in Molecular Biology and 19 papers in Biomaterials. Recurrent topics in Yu Cheng's work include Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (18 papers) and Micro and Nano Robotics (15 papers). Yu Cheng is often cited by papers focused on Nanoplatforms for cancer theranostics (24 papers), Nanoparticle-Based Drug Delivery (18 papers) and Micro and Nano Robotics (15 papers). Yu Cheng collaborates with scholars based in China, United States and Taiwan. Yu Cheng's co-authors include Maciej S. Lesniak, Ramin A. Morshed, Alex L. Tobias, Brenda Auffinger, Yuanhui Ji, Yu Han, Lingjiao Zhang, Derek A. Wainwright, Yingze Li and Zhenguang Li and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Yu Cheng

82 papers receiving 4.1k citations

Peers

Yu Cheng
Nathalie Luciani France
Fei Yan China
Forrest M. Kievit United States
Nitin Joshi United States
Andrew D. Doyle United States
Meng Zheng China
Ming Guo United States
Bobbi K. Lewis United States
Elaine Jordan United States
Erik M. Shapiro United States
Nathalie Luciani France
Yu Cheng
Citations per year, relative to Yu Cheng Yu Cheng (= 1×) peers Nathalie Luciani

Countries citing papers authored by Yu Cheng

Since Specialization
Citations

This map shows the geographic impact of Yu Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Cheng more than expected).

Fields of papers citing papers by Yu Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Cheng. The network helps show where Yu Cheng may publish in the future.

Co-authorship network of co-authors of Yu Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Cheng. A scholar is included among the top collaborators of Yu Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Cheng. Yu Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Gan, et al.. (2025). TAZ/NRF2 positive feedback loop contributes to proliferation in bladder cancer through antagonistic ferroptosis. Cell Death Discovery. 11(1). 208–208. 1 indexed citations
3.
Xie, Xiaoyan, et al.. (2025). Bone marrow mesenchymal stem cells-derived exosomal miR-24–3p alleviates spinal cord injury by targeting MAPK9 to inhibit the JNK/c-Jun/c-Fos pathway. Archives of Biochemistry and Biophysics. 769. 110434–110434. 3 indexed citations
4.
Zhang, Liping, Mingjie Luo, Yu Cheng, et al.. (2025). Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. Cell Death and Disease. 16(1). 170–170. 3 indexed citations
5.
Li, Yuan, Tao Feng, Xiaolei Chen, et al.. (2025). Spatiotemporal neuromodulation via reversible and photothermal-gated DNA nanochannels. 2(2). 100215–100215.
6.
Wu, Xianghua, Lei Zhang, Yifan Tong, et al.. (2024). Self-Adaptive Magnetic Liquid Metal Microrobots Capable of Crossing Biological Barriers and Wireless Neuromodulation. ACS Nano. 18(43). 29558–29571. 6 indexed citations
7.
Wang, Chunlei, Yongkai Li, Xiaolei Yi, et al.. (2024). Peak effects in the kagome superconductors CsV3Sb5 and Cs(V0.93Nb0.07)3Sb5. Physical review. B.. 109(2). 3 indexed citations
8.
Zhang, Wei, Xiaoyong Chen, Yanyun Wang, et al.. (2024). Dual Frequency-Regulated Magnetic Vortex Nanorobots Empower Nattokinase for Focalized Microvascular Thrombolysis. ACS Nano. 18(43). 29492–29506. 9 indexed citations
9.
Pi, Jingjiang, Jie Liu, Huan J. Chang, et al.. (2024). Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis. Redox Biology. 75. 103281–103281. 4 indexed citations
10.
Gao, Shuang, Na Li, Yanwei Chen, et al.. (2023). Inhibition of Ferroptosis Ameliorates Photoreceptor Degeneration in Experimental Diabetic Mice. International Journal of Molecular Sciences. 24(23). 16946–16946. 13 indexed citations
11.
Sun, Ran, Lei Wang, Xiaoyong Chen, et al.. (2022). Biocompatible Iron Oxide Nanoring-Labeled Mesenchymal Stem Cells: An Innovative Magnetothermal Approach for Cell Tracking and Targeted Stroke Therapy. ACS Nano. 16(11). 18806–18821. 32 indexed citations
12.
Cheng, Yu, Long Li, Pei Hu, et al.. (2021). Recent Advances in Stimulus‐Responsive Nanocarriers for Gene Therapy. Advanced Science. 8(14). 2100540–2100540. 105 indexed citations
13.
Li, Zhenguang, Yingze Li, Chang Chen, & Yu Cheng. (2021). Magnetic-responsive hydrogels: From strategic design to biomedical applications. Journal of Controlled Release. 335. 541–556. 159 indexed citations
14.
Cheng, Yu, et al.. (2020). Circular RNA CircPRMT5 Accelerates Proliferation and Invasion of Papillary Thyroid Cancer Through Regulation of miR-30c/E2F3 Axis. SHILAP Revista de lepidopterología. 1 indexed citations
15.
16.
Mansell, Rhodri, Tarun Vemulkar, D. Petit, et al.. (2017). Magnetic particles with perpendicular anisotropy for mechanical cancer cell destruction. Scientific Reports. 7(1). 4257–4257. 38 indexed citations
17.
Wainwright, Derek A., Alan L. Chang, Mahua Dey, et al.. (2014). Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors. Clinical Cancer Research. 20(20). 5290–5301. 448 indexed citations
18.
Wegscheid, Michelle L., Ramin A. Morshed, Yu Cheng, & Maciej S. Lesniak. (2014). The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma. Expert Opinion on Drug Delivery. 11(6). 957–975. 25 indexed citations
19.
Cheng, Yu, Joseph Meyers, Richard S. Agnes, et al.. (2011). Addressing Brain Tumors with Targeted Gold Nanoparticles: A New Gold Standard for Hydrophobic Drug Delivery?. Small. 7(16). 2301–2306. 113 indexed citations
20.
Chen, Jinfu, et al.. (2010). Remarks on Urban Spatial Growth Management Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Luciani Breakdown of academic impact, for papers by Fei Yan Breakdown of academic impact, for papers by Forrest M. Kievit Breakdown of academic impact, for papers by Nitin Joshi Breakdown of academic impact, for papers by Andrew D. Doyle Breakdown of academic impact, for papers by Meng Zheng Breakdown of academic impact, for papers by Ming Guo Breakdown of academic impact, for papers by Bobbi K. Lewis Breakdown of academic impact, for papers by Elaine Jordan Breakdown of academic impact, for papers by Erik M. Shapiro
Rankless by CCL
2026